Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 23 2014
Print

Topics - Clinical Trial Materials


Refine by Date:
From: To:
Published April 7, 2014
To complete studies required for a new manufacturing process Read More »
Published April 3, 2014
Nature and complexity of drug candidates drives increase in use of dedicated supply chain providers Read More »
Published April 1, 2014
Penn to provide Phase III materials and commercial production Read More »
By Kristin Brooks
Published March 25, 2014
To manufacture ADC candidate for Phase I trials Read More »
By Kristin Brooks
Published March 25, 2014
To provide additional cGMP manufacturing services to support Phase II trials of NEO-102 Read More »
By Kristin Brooks
Published March 11, 2014
Establishes centers in Singapore and Japan Read More »
By Kristin Brooks
Published March 3, 2014
Cobra to provide GMP manufacture and aseptic fill/finish of BC-821 Read More »
By Kristin Brooks
Published February 28, 2014
Goodwin to oversee cGMP production of monoclonal antibody for Phase III trial Read More »
By Kristin Brooks
Published February 26, 2014
To manufacture Symphogen’s antibody mixture product candidates Read More »
By Gil Roth
Published February 18, 2014
Capital investments reflect ongoing commitment to contract services Read More »
By Gil Roth
Published February 18, 2014
Orantes to lead U.S. operations Read More »
By Gil Roth
Published February 18, 2014
Will provide mammalian, microbial services to clinical-stage company Read More »
By Kristin Brooks
Published January 27, 2014
Cognate to provide manufacturing and services for DCVax-L and DCVax-Direct Read More »
By Kristin Brooks
Published January 13, 2014
Expanded GMP capabilities include powders, tablets, and hard capsules Read More »
By Kristin Brooks
Published January 13, 2014
To provide clinical and commercial production of IMBRUVICA Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On